The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on December 9.Don't Miss Our ...

In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known ...

The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...

Coming off of Novo Nordisk's (NVO) sharp stock decline after its experimental weight-loss shot CagriSema was found to help ...

"At a time when Israel is fighting on seven fronts, we deeply appreciate the steadfast support of our Christian friends around the world," Netanyahu said. Information ...

U.S. Enters a New Political Era, Defined by Donald Trump The presidential race in 2012 ended a pattern in U.S. politics, which has since become characterized by Mr. Trump’s populism, a Times ...

The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...